Article Text

Download PDFPDF
Endometrial lymphoepitheliomalike carcinoma: absence of Epstein–Barr virus genomes
  1. S. Rahimi*,
  2. A. Lena and
  3. G. Vittori
  1. * Department of Pathology, Ospedale San Carlo-IDI IRCCS, Rome, Italy
  2. Department of Gynaecology, Ospedale San Carlo-IDI IRCCS, Rome, Italy
  1. Address correspondence and reprint requests to: Siavash Rahimi, MD, Department of Pathology, Ospedale San Carlo-IDI IRCCS, Via Aurelia 275, 00165 Rome, Italy. Email: s.rahimi{at}


The aim of this study was to report a case of primary lymphoepitheliomalike endometrial carcinoma (FIGO stage IB). A 57-year-old woman presented with an endometrial tumor showing the classic clinical and hysteroscopic aspects of endometrial carcinoma. Morphologically, the neoplasm was similar to undifferentiated nasopharyngeal carcinoma (lymphoepithelioma). Immunohistochemistry showed that the tumor cells were cyokeratins and epithelial membrane antigen positive. Leucocyte common antigen, estrogen and progesterone receptors, neuron specific enolase, cromogranin, synaptophysin, and p53 were negative. We did not find evidence of Epstein–Barr virus (EBV) infection using immunohistochemistry and polymerase chain reaction (PCR). We report the third case of an endometrial lymphoepitheliomalike carcinoma (LELC). The patient did not receive chemotherapy and is alive and free of disease 24 month after diagnosis. LELC can occur in the endometrium and in this location may not be associated with EBV infection

  • Epstein–Barr virus
  • lymphoepithelioma
  • lymphoepitheliomalike endometrial carcinoma

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.